Literature DB >> 7813531

Monoclonal proliferation of Epstein-Barr virus-infected T-cells in a patient with virus-associated haemophagocytic syndrome.

T Noma1, K Kou, I Yoshizawa, Y Kawano, T Miyashita, S Mizutani, J Yata.   

Abstract

Virus-associated haemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation disorder showing marked haemophagocytosis associated with systemic viral infection. We describe the case of a 1-year-old girl with Epstein-Barr virus (EBV)-related VAHS, in whom Southern blot analysis showed monoclonal proliferation of bone marrow cells with the EBV genome; detected with the Xho-1 fragment of the latent infection membrane protein genome. EBV serology showed anti-Epstein-Barr virus nuclear associated antigen (EBNA), anti-viral capsid antigen (VCA)-IgG, anti-VCA-IgA elevation and positive EBNA of Sheep red blood cells (SRBC)-rosette-forming bone marrow cells in the late period of her clinical course, indicative of EBV infection. DNA analysis of her bone marrow cells showed monoclonal rearrangement of the T-cell receptor-beta and -gamma chain genes but not of the immunoglobulin heavy chain genes. Those results suggest that EBV may infect T-cells, after which the cells proliferate monoclonally. Repeated administration of epipodophyllotoxin VP-16-213 induced remission, but adrenocortical steroid, vincristine, and cyclophosphamide had no effect on the patient's condition. Ours is a first case report of VAHS showing monoclonal proliferation of EBV-infected T-cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813531     DOI: 10.1007/bf01954490

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

2.  Sequence and expression of transcripts of the human T-cell receptor beta-chain genes.

Authors:  Y Yoshikai; D Anatoniou; S P Clark; Y Yanagi; R Sangster; P Van den Elsen; C Terhorst; T W Mak
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

3.  Virus-associated hemophagocytic syndrome due to Epstein-Barr virus.

Authors:  R P Reisman; M A Greco
Journal:  Hum Pathol       Date:  1984-03       Impact factor: 3.466

4.  Virus associated hemophagocytic syndrome.

Authors:  R W McKenna; R J Risdall; R D Brunning
Journal:  Hum Pathol       Date:  1981-05       Impact factor: 3.466

5.  Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses.

Authors:  C V Sumaya; Y Ench
Journal:  Pediatrics       Date:  1985-06       Impact factor: 7.124

6.  Epstein-Barr virus DNA in lymphocytes of patients with the virus-associated hemophagocytic syndrome.

Authors:  K McClain
Journal:  Am J Pediatr Hematol Oncol       Date:  1986

7.  CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA.

Authors:  K Kawa-Ha; S Ishihara; T Ninomiya; K Yumura-Yagi; J Hara; F Murayama; A Tawa; K Hirai
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

8.  T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.

Authors:  J F Jones; S Shurin; C Abramowsky; R R Tubbs; C G Sciotto; R Wahl; J Sands; D Gottman; B Z Katz; J Sklar
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

9.  Rearrangement of immunoglobulin heavy chain genes in human T leukaemic cells shows preferential utilization of the D segment (DQ52) nearest to the J region.

Authors:  S Mizutani; A M Ford; L M Wiedemann; L C Chan; A J Furley; M F Greaves; H V Molgaard
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598

10.  Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection.

Authors:  S Ishihara; A Tawa; K Yumura-Yagi; M Murata; J Hara; H Yabuuchi; K Hirai; K Kawa-Ha
Journal:  Jpn J Cancer Res       Date:  1989-02
View more
  5 in total

Review 1.  The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.

Authors:  Megan C Smith; Daniel N Cohen; Bruce Greig; Ashwini Yenamandra; Cindy Vnencak-Jones; Mary Ann Thompson; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: Report of a case with review of the literature.

Authors:  Miyuki Yoshii; Mitsuaki Ishida; Keiko Hodohara; Hiroko Okuno; Ryota Nakanishi; Takashi Yoshida; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2012-06-12       Impact factor: 2.967

3.  Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.

Authors:  Ken H Young; Dahua Zhang; Jeffery T Malik; Eliot C Williams
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

4.  Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations.

Authors:  Christopher P Fox; Claire Shannon-Lowe; Martin Rowe
Journal:  Herpesviridae       Date:  2011-09-07

5.  Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients.

Authors:  Sanghui Park; Kihyun Kim; Won Seog Kim; Keon Hee Yoo; Hong-Hoe Koo; Young-Hyeh Ko
Journal:  Virchows Arch       Date:  2008-07-18       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.